Liquidia LQDA
NASDAQ LQDA
$71.90 -3.43 (-4.55%)
At close: Aug 20, 2026 · 2:06 PM UTC

Liquidia (LQDA) Selling, General & Administrative (2020 - 2026)

Liquidia (LQDA) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn 317.00 Mn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -1.80 Bn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn 206.70 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 1.13 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 439.70 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn 449.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Liquidia 6.39 Bn 6.10 Bn 160.92 Mn 57.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 57.43 Mn
Mar 31, 2026 46.94 Mn
Dec 31, 2025 48.24 Mn
Sep 30, 2025 40.06 Mn
Jun 30, 2025 38.82 Mn
Mar 31, 2025 30.06 Mn
Dec 31, 2024 21.20 Mn
Sep 30, 2024 20.18 Mn
Jun 30, 2024 19.94 Mn
Mar 31, 2024 20.25 Mn
Dec 31, 2023 17.15 Mn
Sep 30, 2023 10.56 Mn
Jun 30, 2023 9.25 Mn
Mar 31, 2023 7.79 Mn
Dec 31, 2022 6.19 Mn
Sep 30, 2022 6.74 Mn
Jun 30, 2022 6.94 Mn
Mar 31, 2022 12.54 Mn
Dec 31, 2021 8.47 Mn
Sep 30, 2021 4.88 Mn